Post by NOUL Co., Ltd.

Exciting news! miLab™ CER has received regulatory approval in Peru. This milestone represents an important step in expanding access to AI-powered cervical cancer screening solutions across Latin America and supporting healthcare providers with innovative doagnostic technolgies. We look forward to working with our partners in Peru to help advance cervical cancer screening and improve access to quality diagnostics. 📩 For more information about miLab™ CER, please contact: [email protected] #CervicalCancerScreening #DigitalCytology #ArtificialIntelligence #WomensHealth #Peru #LATAM #miLabCER #Noul